Quarterly report pursuant to Section 13 or 15(d)

Schedule of Capitalized Technology (Details)

v3.23.1
Schedule of Capitalized Technology (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Research and Development [Abstract]    
Balance, beginning of period $ 64,499 $ 43,038
Additional capitalized cost 29,800 45,196
Provision for amortization (10,605) (23,735)
Balance, end of period $ 83,694 $ 64,499